USD 0.67
(-0.95%)
Year | Inventory | Inventory Growth |
---|---|---|
2023 | - USD | -100.0% |
2022 | 264 Thousand USD | 83.33% |
2021 | 144 Thousand USD | -30.77% |
2020 | 208 Thousand USD | 7.77% |
2019 | 193 Thousand USD | -53.16% |
2018 | 412 Thousand USD | 562.92% |
2017 | -89 Thousand USD | -285.42% |
2016 | 48 Thousand USD | 100.98% |
2015 | -4.91 Million USD | -6830.14% |
2014 | 73 Thousand USD | 0.0% |
2013 | - USD | 0.0% |
2012 | - USD | 0.0% |
Year | Inventory | Inventory Growth |
---|---|---|
2023 FY | - USD | -100.0% |
2023 Q2 | - USD | 0.0% |
2023 Q4 | - USD | 0.0% |
2023 Q1 | - USD | 0.0% |
2023 Q3 | - USD | 0.0% |
2022 Q2 | - USD | 0.0% |
2022 Q3 | - USD | 0.0% |
2022 Q4 | - USD | 0.0% |
2022 FY | 264 Thousand USD | 83.33% |
2022 Q1 | - USD | -100.0% |
2021 Q1 | - USD | -100.0% |
2021 FY | 144 Thousand USD | -30.77% |
2021 Q3 | - USD | 0.0% |
2021 Q4 | 144 Thousand USD | 0.0% |
2021 Q2 | - USD | 0.0% |
2020 FY | 208 Thousand USD | 7.77% |
2020 Q1 | - USD | 0.0% |
2020 Q2 | - USD | 0.0% |
2020 Q3 | - USD | 0.0% |
2020 Q4 | 208 Thousand USD | 0.0% |
2019 Q1 | - USD | 0.0% |
2019 FY | 193 Thousand USD | -53.16% |
2019 Q4 | - USD | 0.0% |
2019 Q3 | - USD | 0.0% |
2019 Q2 | - USD | 0.0% |
2018 Q4 | - USD | 0.0% |
2018 Q2 | - USD | 0.0% |
2018 Q1 | - USD | 0.0% |
2018 FY | 412 Thousand USD | 562.92% |
2018 Q3 | - USD | 0.0% |
2017 FY | -89 Thousand USD | -285.42% |
2017 Q2 | - USD | 0.0% |
2017 Q3 | - USD | 0.0% |
2017 Q1 | - USD | 0.0% |
2017 Q4 | - USD | 0.0% |
2016 Q2 | - USD | 0.0% |
2016 FY | 48 Thousand USD | 100.98% |
2016 Q4 | - USD | 0.0% |
2016 Q3 | - USD | 0.0% |
2016 Q1 | - USD | 0.0% |
2015 Q2 | - USD | 0.0% |
2015 Q1 | - USD | -100.0% |
2015 FY | -4.91 Million USD | -6830.14% |
2015 Q4 | - USD | 0.0% |
2015 Q3 | - USD | 0.0% |
2014 Q1 | - USD | 0.0% |
2014 FY | 73 Thousand USD | 0.0% |
2014 Q2 | - USD | 0.0% |
2014 Q4 | 73 Thousand USD | 0.0% |
2013 Q1 | - USD | 0.0% |
2013 FY | - USD | 0.0% |
2013 Q3 | - USD | 0.0% |
2013 Q4 | - USD | 0.0% |
2012 FY | - USD | 0.0% |
Name | Inventory | Inventory Difference |
---|---|---|
Aclaris Therapeutics, Inc. | - USD | NaN% |
Applied DNA Sciences, Inc. | 330.02 Thousand USD | 100.0% |
Aspira Women's Health Inc. | 227 Thousand USD | 100.0% |
Biodesix, Inc. | 1.4 Million USD | 100.0% |
BioNexus Gene Lab Corp. | 1.13 Million USD | 100.0% |
bioAffinity Technologies, Inc. | 18.48 Thousand USD | 100.0% |
bioAffinity Technologies, Inc. | 18.48 Thousand USD | 100.0% |
Bionano Genomics, Inc. | 22.89 Million USD | 100.0% |
CareDx, Inc | 19.47 Million USD | 100.0% |
Castle Biosciences, Inc. | 7.94 Million USD | 100.0% |
DarioHealth Corp. | 5.06 Million USD | 100.0% |
Exact Sciences Corporation | 127.47 Million USD | 100.0% |
Fulgent Genetics, Inc. | 5.82 Million USD | 100.0% |
Guardant Health, Inc. | 61.94 Million USD | 100.0% |
ICON Public Limited Company | 1.00 USD | 100.0% |
IDEXX Laboratories, Inc. | 380.28 Million USD | 100.0% |
Illumina, Inc. | 587 Million USD | 100.0% |
Intelligent Bio Solutions Inc. | 777.53 Thousand USD | 100.0% |
iSpecimen Inc. | - USD | NaN% |
Standard BioTools Inc. | 20.53 Million USD | 100.0% |
MDxHealth SA | 2.77 Million USD | 100.0% |
23andMe Holding Co. | 12.46 Million USD | 100.0% |
Medpace Holdings, Inc. | 1.00 USD | 100.0% |
Myriad Genetics, Inc. | 20.1 Million USD | 100.0% |
Mainz Biomed B.V. | 613.63 Thousand USD | 100.0% |
ENDRA Life Sciences Inc. | 2.62 Million USD | 100.0% |
NeoGenomics, Inc. | 24.15 Million USD | 100.0% |
Neogen Corporation | 189.26 Million USD | 100.0% |
Inotiv, Inc. | 56.1 Million USD | 100.0% |
Natera, Inc. | 40.75 Million USD | 100.0% |
OpGen, Inc. | 1.00 USD | 100.0% |
OPKO Health, Inc. | 65.69 Million USD | 100.0% |
Psychemedics Corporation | 1.00 USD | 100.0% |
Prenetics Global Limited | 3.12 Million USD | 100.0% |
Prenetics Global Limited | 3.12 Million USD | 100.0% |
Precipio, Inc. | 384 Thousand USD | 100.0% |
Personalis, Inc. | 5.66 Million USD | 100.0% |
RadNet, Inc. | 1.00 USD | 100.0% |
Sera Prognostics, Inc. | - USD | NaN% |
Sotera Health Company | 51.98 Million USD | 100.0% |
Neuronetics, Inc. | 8.09 Million USD | 100.0% |
Star Equity Holdings, Inc. | 3.42 Million USD | 100.0% |
Star Equity Holdings, Inc. | 3.42 Million USD | 100.0% |
Trinity Biotech plc | 19.93 Million USD | 100.0% |
T2 Biosystems, Inc. | 4.81 Million USD | 100.0% |
Twist Bioscience Corporation | 32.06 Million USD | 100.0% |
Exagen Inc. | 2.87 Million USD | 100.0% |